Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer

Prostate cancer is the second most common cancer in men, with 1.1 million new cases worldwide reported by the World Health Organization in one recent year. Transrectal ultrasound (TRUS)-guided biopsy has been used for the diagnosis of prostate cancer for over 2 decades, but the technique is usually blind to cancer location. Moreover, the false negative rate of TRUS biopsy has been reported to be as high as 47%. Multiparametric magnetic resonance imaging (mp-MRI) includes T1- and T2-weighted imaging as well as dynamic contrast-enhanced (DCE) and diffusion-weighted imaging (DWI). mp-MRI is a major advance in the imaging of prostate cancer, enabling targeted biopsy of suspicious lesions. Evolving targeted biopsy techniques—including direct in-bore biopsy, cognitive fusion and software-based MRI-ultrasound (MRI-US) fusion—have led to a several-fold improvement in cancer detection compared to the earlier method. Importantly, the detection of clinically significant cancers has been greatly facilitated by targeting, compared to systematic biopsy alone. Targeted biopsy via MRI-US fusion may dramatically alter the way prostate cancer is diagnosed and managed.

[1]  B. K. Park,et al.  Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. , 2011, AJR. American journal of roentgenology.

[2]  C. Siegel.  Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2005, The Journal of urology.

[3]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[4]  J. Epstein,et al.  The vanishing prostate cancer phenomenon. , 2010, Urology.

[5]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[6]  J. Presti.  Prostate biopsy strategies , 2007, Nature Clinical Practice Urology.

[7]  Thomas Hambrock,et al.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.

[8]  Aaron Fenster,et al.  Clinical application of a 3D ultrasound-guided prostate biopsy system. , 2011, Urologic oncology.

[9]  Georgios Sakas,et al.  A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. , 2011, The Journal of urology.

[10]  D L McCullough,et al.  Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. , 1997, The Journal of urology.

[11]  Baris Turkbey,et al.  Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? , 2013, Radiology.

[12]  T. Stamey,et al.  Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. , 1989, The Journal of urology.

[13]  Tsuyoshi Mitake,et al.  Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data , 2010, International journal of urology : official journal of the Japanese Urological Association.

[14]  W. Catalona,et al.  Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.

[15]  P. Choyke,et al.  D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. , 2010, The Journal of urology.

[16]  R. Lenkinski,et al.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 tesla endorectal, in vivo T2‐weighted MR imagery , 2012, Journal of magnetic resonance imaging : JMRI.

[17]  P. Albers,et al.  Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard , 2013, European Radiology.

[18]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[19]  H. Hricak,et al.  Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.

[20]  H. Schlemmer,et al.  Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.

[21]  Fernando J. Kim,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011 .

[22]  C Fraser,et al.  The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. , 2013, Health technology assessment.

[23]  B. K. Park,et al.  Comparison of Phased-Array 3.0-T and Endorectal 1.5-T Magnetic Resonance Imaging in the Evaluation of Local Staging Accuracy for Prostate Cancer , 2007, Journal of computer assisted tomography.

[24]  M. Cooperberg,et al.  The changing face of prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  L. Klotz,et al.  Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. , 2002, Urology.

[26]  K. Wallner,et al.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.

[27]  W. Ellis,et al.  Improved prostate cancer detection with anterior apical prostate biopsies. , 2006, Urologic oncology.

[28]  Baris Turkbey,et al.  Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. , 2012, The Journal of urology.

[29]  A. Evans,et al.  ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging , 2010, BJU international.

[30]  A. Weaver,et al.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. , 2001, The Journal of urology.

[31]  Roberto Passariello,et al.  Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.

[32]  T. Koyanagi,et al.  Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy , 2004, The Prostate.

[33]  K. Fareed,et al.  Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. , 2011, The Journal of urology.

[34]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[35]  A. Partin,et al.  Multiparametric magnetic resonance imaging findings in men with low‐risk prostate cancer followed using active surveillance , 2013, BJU international.

[36]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[37]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[38]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[39]  K. Shinohara,et al.  The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. , 2000, The Journal of urology.

[40]  K. Fareed,et al.  Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer. , 2010, Urology.

[41]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[42]  Xavier Leroy,et al.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. , 2011, Urology.

[43]  Shyam Natarajan,et al.  MRI–ultrasound fusion for guidance of targeted prostate biopsy , 2013, Current opinion in urology.

[44]  Paul R Young,et al.  Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. , 2005, Urology.

[45]  M. Barry,et al.  Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. , 2007, Journal of the National Cancer Institute.

[46]  P. Scardino,et al.  The clinical features of anterior prostate cancers , 2006, BJU international.

[47]  Katarzyna J Macura,et al.  MR-guided biopsy of the prostate: an overview of techniques and a systematic review. , 2008, European urology.

[48]  B. Kiefer,et al.  Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device , 2006, European Radiology.

[49]  D. Johnston,et al.  A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.

[50]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[51]  D. Schilling,et al.  MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy , 2012, World Journal of Urology.

[52]  S. Bott,et al.  Anterior prostate cancer: is it more difficult to diagnose? , 2002, BJU international.

[53]  Xavier Leroy,et al.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.

[54]  Raj Persad,et al.  Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? , 2013, Journal of magnetic resonance imaging : JMRI.

[55]  R W Veltri,et al.  Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. , 2000, Urology.

[56]  M. Dall’Era.  The economics of active surveillance for prostate cancer , 2013, Current opinion in urology.

[57]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[58]  B. McNeil,et al.  Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate Cancer. Results of a Multi-Institutional Cooperative Trial , 1991, Investigative Radiology.

[59]  Baris Turkbey,et al.  Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. , 2012, Medical physics.

[60]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[61]  Robert W Veltri,et al.  Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. , 2003, The Journal of urology.

[62]  Clare Allen,et al.  How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.

[63]  Ralph Strecker,et al.  Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. , 2011, Radiology.

[64]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[65]  P. Walsh.  Anterior-predominant prostatic tumors: Zone of origin and pathologic outcomes at radical prostatectomy , 2010 .

[66]  Gary Liney,et al.  Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.

[67]  T. Wheeler,et al.  Predictors of prostate cancer after initial negative systematic 12 core biopsy. , 2004, The Journal of urology.

[68]  Matthew T Gettman,et al.  Reassessing the diagnostic yield of saturation biopsy of the prostate. , 2008, European urology.

[69]  Gaelle Fiard,et al.  Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. , 2013, Urology.

[70]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[71]  J. McNeal,et al.  Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. , 2002, The Journal of urology.

[72]  Xavier Leroy,et al.  Peripheral zone prostate cancers: Location and intraprostatic patterns of spread at histopathology , 2009, The Prostate.

[73]  Axel Semjonow,et al.  Twenty Years of PSA: From Prostate Antigen to Tumor Marker. , 2007, Reviews in urology.

[74]  Baris Turkbey,et al.  Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla , 2012, BJU international.

[75]  N Karssemeijer,et al.  Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis , 2012, Physics in medicine and biology.

[76]  Raphael Bueno,et al.  Prostate biopsy: past, present, and future. , 2007, Urology.

[77]  P Tiwari,et al.  Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection , 2012, NMR in biomedicine.

[78]  J. Jones,et al.  Rectal sensation test helps avoid pain of apical prostate biopsy. , 2003, The Journal of urology.

[79]  Pingkun Yan,et al.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.

[80]  J. Presti.  Repeat prostate biopsy--when, where, and how. , 2009, Urologic oncology.

[81]  Jelle O. Barentsz,et al.  Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal–pelvic phased-array coils , 2007, European Radiology.

[82]  G P Liney,et al.  Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd‐DTPA‐enhanced MR imaging and histopathology , 1999, Journal of magnetic resonance imaging : JMRI.

[83]  P. Box.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer , 2011 .

[84]  M. Miller,et al.  Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. , 1998, Urology.